Principal Securities’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,058
Closed -$311K 1432
2025
Q4
$311K Buy
3,058
+111
+4% +$8.91K ﹤0.01% 1131
2025
Q3
$161K Buy
2,947
+687
+30% +$34.3K ﹤0.01% 1385
2025
Q2
$120K Sell
2,260
-3,794
-63% -$193K ﹤0.01% 1459
2025
Q1
$340K Hold
6,054
0.01% 924
2024
Q4
$340K Sell
6,054
-1,772
-23% -$110K 0.01% 918
2024
Q3
$533K Sell
7,826
-1,269
-14% -$71.6K 0.01% 735
2024
Q2
$384K Sell
9,095
-279
-3% -$15.4K 0.01% 799
2024
Q1
$647K Sell
9,374
-127
-1% -$8.03K 0.02% 574
2023
Q4
$703K Buy
+9,501
New +$623K 0.03% 499

Other funds holding EXAS

Principal Securities's EXAS Position: Q1 2026 in Review

Principal Securities sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,058 shares — an estimated $311K sold.

Principal Securities first reported a position in EXAS in Q4 2023 and held it in 9 quarters. The position peaked at $703K in Q4 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Principal Securities reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Principal Securities sold 3,058 Exact Sciences shares in Q1 2026, an estimated $311K.
  • Principal Securities first reported a position in Exact Sciences in Q4 2023 and held it in 9 quarters.
  • Principal Securities's Exact Sciences position peaked at $703K in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.